Pharmacokinetics (PK) of hydroxyurea (HU) in children with sickle cell anemia (SCA).

被引:0
|
作者
Parasuraman, S
Rodman, JH
Ware, RE
Liu, A
Wynn, L
Wang, WC
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Tennessee, Memphis, TN USA
[3] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3116
引用
收藏
页码:32B / 33B
页数:2
相关论文
共 50 条
  • [1] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza, A
    Bisotti, R
    Gonzalez, S
    Costa, M
    Hernandez, M
    Pinto, S
    Sumoza, D
    Fairbanks, VF
    [J]. BLOOD, 1998, 92 (10) : 35B - 35B
  • [2] Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)
    Sumoza, A
    de Bisotti, R
    Sumoza, D
    Fairbanks, V
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (03) : 161 - 165
  • [3] Hydroxyurea pharmacokinetics in children with sickle cell anemia
    Harrod, Virginia L.
    Sparreboom, Alex
    Nicole, Mortier
    Susan, Strawn
    Howard, Thad
    Ware, Russell E.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 613 - 613
  • [4] Pharmacokinetics of Hydroxyurea Therapy in African Children with Sickle Cell Anemia: A Noharm Ancillary PK Study
    Marahatta, Anu
    Dong, Min
    Opoka, Robert
    McElhinney, Kathryn E.
    Latham, Teresa S.
    John, Chandy C.
    Vinks, Alexander A.
    Ware, Russell E.
    [J]. BLOOD, 2017, 130
  • [5] Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
    Ware, Russell E.
    Despotovic, Jenny M.
    Mortier, Nicole A.
    Flanagan, Jonathan M.
    He, Jin
    Smeltzer, Matthew P.
    Kimble, Amy C.
    Aygun, Banu
    Wu, Song
    Howard, Thad
    Sparreboom, Alex
    [J]. BLOOD, 2011, 118 (18) : 4985 - 4991
  • [6] Pharmacokinetics and Bioequivalence of a Liquid Formulation of Hydroxyurea in Children With Sickle Cell Anemia
    Estepp, Jeremie H.
    Melloni, Chiara
    Thornburg, Courtney D.
    Wiczling, Pawel
    Rogers, Zora
    Rothman, Jennifer A.
    Green, Nancy S.
    Liem, Robert
    Brandow, Amanda M.
    Crary, Shelley E.
    Howard, Thomas H.
    Morris, Maurine H.
    Lewandowski, Andrew
    Garg, Uttam
    Jusko, William J.
    Neville, Kathleen A.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 298 - 306
  • [7] Hydroxyurea Pharmacokinetics for Predicting Maximum Tolerated Dose in Children with Sickle Cell Anemia
    McGann, Patrick T.
    Sparreboom, Alex
    Mortier, Nicole A.
    Aygun, Banu
    Howard, Thad A.
    Nottage, Kerri
    Ware, Russell E.
    [J]. BLOOD, 2014, 124 (21)
  • [8] Hydroxyurea Pharmacokinetics and Fetal Hemoglobin Response in Ugandan Children with Sickle Cell Anemia
    Power-Hays, Alexandra
    Dong, Min
    McElhinney, Kathryn
    Conroy, Andrea L.
    Latham, Teresa
    Lane, Adam
    Opoka, Robert O.
    Vinks, Alexander A.
    Ware, Russell E.
    [J]. BLOOD, 2022, 140 : 5461 - 5462
  • [9] FOLLOW-UP OF HYDROXYUREA (HU) IN INFANTS WITH SICKLE CELL ANEMIA(SCA): FINDINGS FROM BABY HUG STUDIES
    Rogers, Zora
    Assmann, Susan
    Lebensburger, Jeffrey
    Brown, R. Clark
    Majumdar, Suvankar
    Casella, James
    Rothman, Jennifer
    Sarnaik, Sharada
    Alvarez, Ofelia
    Luban, Naomi
    Rana, Sohail
    Jackson, Sherron
    Hamza, Taye
    Waclawiw, Myron
    Werner, Ellen
    Miller, Scott
    Wang, Winfred
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S6 - S7
  • [10] Safety and hematologic efficacy of four years of hydroxyurea (HU) therapy for very young children with sickle cell anemia (SCA): The HUSOFT Extension Study.
    Rogers, ZR
    Ware, RE
    Wynn, LW
    Scott, JP
    Lane, PA
    Wang, WC
    [J]. BLOOD, 2001, 98 (11) : 489A - 489A